期刊文献+

肠道在非酒精性脂肪性肝病发病中的病理生理作用 被引量:2

The pathophysiological role of gut in non-alcoholic fatty liver disease
原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD)是造成慢性肝功能异常的重要原因。随着病程进展出现多水平的代谢异常,常常伴有其他重要脏器损伤,为NAFLD的诊治带来巨大的困难删。现有的临床试验初步证明改善肠黏膜屏障功能的治疗有可能为肝脏疾病带来了更好的治疗和预后。现就肠道在NAFLD发病中的病理生理作用作一综述。
作者 刘玉兰 李晶
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2011年第9期651-652,共2页 Chinese Journal of Hepatology
关键词 脂肪肝 胃肠道 屏障 机制 Fatty liver Gastrointestinal tract Barrier Mechanism
  • 相关文献

参考文献21

  • 1Sanyal AJ. NASH: a global health problem. Hepatol Res, 2011, 41: 670-674.
  • 2Day CP. Non-alcoholic fatty liver disease: a massive problem. Clin Med, 2011, 11: 176-178.
  • 3Day CP, James OF. Steatohepatitis: a tale of two"hits"? Gastroenterology, 1998, 114: 842-845.
  • 4Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol, 2011, 5: 189-200.
  • 5Soardo G, Donnini D, Domenis L, et al. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord, 2011, In press.
  • 6Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol, 2011, 7: 691-701.
  • 7Musso G, Gambino R, Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curt Opin Lipidol, 2010, 21: 76-83.
  • 8Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care, 2010, 33: 2277-2284.
  • 9Szabo G, Bala S, Petrasek J, et al. Gut-liver axis and sensing microbes. Dig Dis, 2010, 28: 737-744.
  • 10Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non- alcoholic steatohepatitis. Clin Chim Acta, 2011, 412: 1297-1305.

同被引文献21

  • 1潘国宗.肠易激综合征发病机制研究的进展[J].胃肠病学和肝病学杂志,2004,13(4):333-334. 被引量:24
  • 2郑娉娉,王炳元.非酒精性脂肪性肝痫与酒精性肝病的异同.中华旰脏病杂志2011;19:715-717.
  • 3中华医学会肝脏病学分会脂肪肝和酒精性脂肪肝病学组非酒精性脂肪性肝病诊疗指南.中华肝畦病杂志2006;14:164-166.
  • 4中华医学会消化病学分会胃肠动力学组肠易激综合征诊断和治疗共识意见(长沙,2009).中华消化杂志2008;28:38-40.
  • 5Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4:686-693 [PMID: 15084161 DOI: 10.1111/j.1600-6143.2004.00432.x].
  • 6Watanabe S, Yaginuma R, Ikejima K, Miyazaki A. Liver diseases and metabolic syndrome. J Gas- troenterol 2008; 43:509-518 [PMID: 18648737 DOI: 10,1007/s00535-008-2193-6].
  • 7Boppidi H, Daram SR. Nonalcoholic fatty liver dis-ease: hepatic manifestation of obesity and the meta- bolic syndrome. Postgrad Med 2008; 120:E01-E07 [PMID: 18654060 DOI: 10.3810/pgm.2008.07.1800].
  • 8Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Rev Gastroen- terol Hepatol 2011; 5:189-200 [PMID: 21476914 DOI: 10.1586/egh.11.21].
  • 9Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 2011; 412:1297-1305 [PMID: 21514287 DOI: 10.1016/i.cca.2011.04.0131.
  • 10Hotamisligil GS. Inflammation and metabolic dis- orders. Nature 2006; 444:860-867 [PMID: 17167474 DOI: 10.1038/nature05485].

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部